Elkhorn Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-600
Closed -$87K 51
2022
Q2
$87K Buy
600
+250
+71% +$36.3K 0.06% 28
2022
Q1
$41K Hold
350
0.02% 38
2021
Q4
$48K Buy
+350
New +$48K 0.03% 31
2021
Q2
Sell
-1,000
Closed -$68K 54
2021
Q1
$68K Buy
+1,000
New +$68K 0.04% 28